Skip to main content
Premium Trial:

Request an Annual Quote

Sony DADC to Manufacture MyCartis Biomarker Analysis Cartridges

NEW YORK (GenomeWeb) – MyCartis announced today that it has signed a deal to have the microfluidic assay cartridges for its Evaluation multiplex biomarker analysis platform manufactured at Sony DADC Biosciences' facility in Salzburg, Austria.

MyCartis, a joint venture of Biocartis and Pronota, was launched in late 2014. The Evaluation platform is intended for simultaneous analysis of multiple protein and nucleic acid markers.

Under the newly announced agreement, Sony DADC BioSciences will manufacture the cartridges for use in clinical and pharmaceutical research applications at its Salzburg, Austria facility. Specific terms of the arrangement were not disclosed.

"The collaboration between the two companies brings together a broad range of knowledge and experience," MyCartis CEO Joris Schuurmans said in a statement.

"From a manufacturing perspective, the project enhances our capabilities in both injection molding and bonding of microfluidic consumables in microtiter plate format — the de facto industry standard," added Werner Balika, engineering manager at Sony DADC BioSciences.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.